Literature DB >> 19131527

Selection of candidates for lung transplantation.

Maryl Kreider1, Robert M Kotloff.   

Abstract

The selection of candidates for lung transplantation requires an appreciation of the natural history of lung disease to determine when the disease has entered an advanced and imminently life-threatening stage. It also requires an understanding of the impact of preexisting medical comorbidities on transplant outcomes. Finally, selection is influenced by the particular metric by which outcomes are judged to be successful (e.g., maximizing short-term net survival benefit versus maximizing post-transplant longevity). This article will discuss general and disease-specific criteria used to select patients for lung transplantation and determine the appropriate timing of listing. It will highlight current guidelines put forth by the International Society of Heart and Lung Transplantation and will explore the published data upon which these guidelines are based.

Entities:  

Mesh:

Year:  2009        PMID: 19131527     DOI: 10.1513/pats.200808-097GO

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  11 in total

1.  Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded.

Authors:  Andrew P Price; Kristen A England; Amy M Matson; Bruce R Blazar; Angela Panoskaltsis-Mortari
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

Review 2.  Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management.

Authors:  Patrick Hofmann; Christian Benden; Malcolm Kohler; Macé M Schuurmans
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 3.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

4.  Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients.

Authors:  George J Arnaoutakis; Jeremiah G Allen; Christian A Merlo; William A Baumgartner; John V Conte; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2010-07-14       Impact factor: 10.247

Review 5.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

6.  Short-term outcomes of cadaveric lung transplantation in ventilator-dependent patients.

Authors:  Hsao-Hsun Hsu; Jin-Shing Chen; Wen-Je Ko; Shu-Chien Huang; Shuenn-Wen Kuo; Pei-Ming Huang; Nai-Hsin Chi; Chin-Chih Chang; Robert J Chen; Yung-Chie Lee
Journal:  Crit Care       Date:  2009-08-06       Impact factor: 9.097

7.  The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis.

Authors:  Jianmin Xue; Bernadette R Gochuico; Ahmad Samer Alawad; Carol A Feghali-Bostwick; Imre Noth; Steven D Nathan; Glenn D Rosen; Ivan O Rosas; Sanja Dacic; Iclal Ocak; Carl R Fuhrman; Karen T Cuenco; Mary A Smith; Susan S Jacobs; Adriana Zeevi; Penelope A Morel; Joseph M Pilewski; Vincent G Valentine; Kevin F Gibson; Naftali Kaminski; Frank C Sciurba; Yingze Zhang; Steven R Duncan
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

Review 8.  Extracorporeal life support as bridge to lung transplantation: a systematic review.

Authors:  Davide Chiumello; Silvia Coppola; Sara Froio; Andrea Colombo; Lorenzo Del Sorbo
Journal:  Crit Care       Date:  2015-01-22       Impact factor: 9.097

9.  Preoperative cardiac variables of diastolic dysfunction and clinical outcomes in lung transplant recipients.

Authors:  Ajay Yadlapati; Joseph P Lynch; Rajan Saggar; David Ross; John A Belperio; Stephen Weigt; Abbas Ardehali; Tristan Grogan; Eric H Yang; Jamil Aboulhosn
Journal:  J Transplant       Date:  2013-09-12

10.  Timing and Amount of Physical Therapy Treatment are Associated with Length of Stay in the Cardiothoracic ICU.

Authors:  Audrey M Johnson; Angela N Henning; Peter E Morris; Alejandro G Villasante Tezanos; Esther E Dupont-Versteegden
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.